Clinical Trial Update: Evolution of Metabolic and Immune Dysfunction in In-transit Melanoma

View source ↗

Summary

A clinical trial examining the evolution of metabolic and immune dysfunction in melanoma patients, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: Yana Najjar | Conditions: Melanoma | Status: RECRUITING